Dupixent Lymphoma: What a Free Case Review Involves

Last updated: October 2026

A free Dupixent lymphoma case review is a no-cost first look at whether your situation may fit the current lawsuits. You share a few basic facts about your Dupixent use and your diagnosis. A participating law firm may then review them and contact you to talk about your options. Asking does not commit you to anything. If you are weighing whether to ask about a Dupixent lymphoma claim, knowing what to expect can make that first step feel easier and less stressful.

This guide walks through what a case review involves, step by step. It covers what you will be asked, what happens to your information and what it does and does not mean.

Why people are asking about Dupixent and lymphoma

Dupixent (dupilumab) is an injectable drug used for eczema, asthma and several other conditions. Some people who used it were later diagnosed with cutaneous T-cell lymphoma (CTCL), a cancer that appears in the skin. The most common forms are mycosis fungoides and Sézary syndrome.

In June 2026, federal cases claiming Dupixent caused or sped up CTCL were combined into MDL No. 3180 in the District of New Jersey. The drug makers, Regeneron and Sanofi, deny the claims. No case has been tried or settled, and there are no settlement amounts.

Because the litigation is new, many people are unsure whether their situation fits. A case review is one way to find out.

What a free case review is, and what it is not

A case review is an initial screening. It helps a participating law firm decide whether it can look more closely at your situation.

What it is

• A short set of questions about your Dupixent use and diagnosis.
• A chance for a firm to see whether your facts may match the claims being filed.
• Free to you, with no obligation to go further.

What it is not

• It is not legal advice.
• It does not create an attorney-client relationship on its own.
• It does not promise that a firm will take your case or that you will receive money.

Direct2Attorney is a legal marketing and referral service, not a law firm. We help connect people with participating law firms that make their own decisions.

Step by step: how the review works

Step 1: Share basic information

You fill out a short online form or call. Most forms ask for your name, contact details, state and a few yes-or-no questions.

Step 2: A participating firm reviews it

Your answers go to a participating law firm. The firm looks at whether your situation may fit its criteria for Dupixent cases.

Step 3: A follow-up conversation

If the firm wants to learn more, someone may contact you by phone or email. They may ask more detailed questions and explain how the process works. You can ask questions too.

Questions you might ask on the call

• How many Dupixent cases is the firm handling?
• Would my case be filed in the federal MDL or in state court?
• Who will be my main contact, and how often will I hear from them?
• What records should I start gathering now?

Step 4: You decide

If the firm offers to represent you, it will explain its terms in writing. You can take time to think about it, ask family, or get another opinion. You are never required to sign.

What you will likely be asked

Having these answers ready can make the review faster. It is fine if you don’t know every detail yet.

• Dupixent use: About when you started, how long you used it and whether you still use it.
• What it was for: For example, eczema, asthma or another condition.
• Diagnosis: What type of lymphoma, such as mycosis fungoides or Sézary syndrome, and roughly when you were diagnosed.
• Biopsy: Whether a skin biopsy or other test confirmed it.
• Treating doctors: Your dermatologist, oncologist or cancer center.
• Other legal help: Whether you already have a lawyer for this issue.

If you are asking for a loved one who has died, you may be asked about your relationship and whether an estate has been opened.

What it costs and how firms are usually paid

The review itself is free. In drug injury cases, many firms work on a contingency fee. That means the fee is a percentage of any recovery, and it is agreed to in advance. The American Bar Association’s model rule on fees says contingent fee agreements should be in writing and explain how the fee is figured.

Ask any firm about:

• The fee percentage and whether it changes at different stages.
• Which case costs you might be responsible for, and when.
• Whether costs are taken out before or after the fee is figured.
• How and when you will get updates.

Under the model rule, a contingent fee agreement is signed by the client and explains the percentage that applies at settlement, trial or appeal. It also says which expenses you may owe no matter how the case ends. Read it carefully before you sign.

Your privacy during a case review

Health information is personal, and a cancer diagnosis even more so. When you ask for a review:

• Share only what the form asks for. You do not need to upload medical records at first.
• Your information is used to connect you with a participating firm about your possible claim.
• You can ask a firm how it stores and protects your information.

If a firm later needs your records, it will ask for your written permission first.

When to ask for a review

Filing deadlines, called statutes of limitations, vary by state and claim type. In some states, the clock may start when you were diagnosed or when you first had reason to connect your illness to a drug. Waiting can risk missing a deadline.

The number of cases is also growing. The JPML’s August 2026 report listed 28 pending actions in MDL 3180, up from the 15 first transferred. Early steps in the MDL are happening now.

You do not need all your records to start. But it helps to begin collecting pharmacy history, biopsy reports and dated photos of your skin.

A Simple Checklist Before Your Dupixent Lymphoma Case Review

You do not need a full file to ask for a review. But a few minutes of prep can make the first call shorter and more useful. Here is a simple Dupixent lymphoma checklist you can work through in a week or less.

Day 1: Write down the basics

• The year you first used Dupixent, even if it is a rough guess.
• Whether you still use it, and if not, about when you stopped.
• The condition it was prescribed for.
• The type of Dupixent lymphoma diagnosis you received, such as mycosis fungoides or Sézary syndrome, and the month or year.

Days 2 and 3: List your doctors and pharmacies

Write the names of the dermatologist who prescribed Dupixent, the doctor who did your biopsy and any cancer center where you are treated. Add the specialty pharmacy that shipped your doses.

Days 4 and 5: Gather what you already have

Look for anything already in your home or patient portal. This might include a pathology report, a cancer center letter, pharmacy labels or insurance statements. Put them in one folder, but do not worry about missing pieces yet.

Days 6 and 7: Prepare your questions

Write down what matters most to you. It might be cost, timing, privacy or how often you will hear from the firm. Keep the list by the phone so you remember to ask.

If you are asking on behalf of a loved one, add their full name, date of birth and, if they have died, the date of death. Note whether anyone has been named to handle their estate.

What Happens If a Firm Takes Your Dupixent Lymphoma Case

A case review is only the first step. If a participating law firm offers to represent you and you agree, the work moves into a new phase. Knowing what comes next can make the process feel less mysterious.

Signing a written agreement

The firm will send you a fee agreement to read and sign. Under the American Bar Association’s model rule on fees, if lawyers from different firms will share the fee, the client must agree to the arrangement, including each lawyer’s share, in writing. Ask the firm to explain any part you do not understand.

Giving permission for records

You will likely sign HIPAA authorization forms. These let the firm request records from your doctors, pharmacies and insurers. The firm then builds a file that shows your Dupixent use and your Dupixent lymphoma diagnosis.

Filing the case

If your case is filed in federal court, it will usually become part of MDL No. 3180 in New Jersey. Under 28 U.S.C. § 1407, cases sent to an MDL are there for pretrial proceedings and are to be sent back to the court where they started by the end of that stage, unless they have already ended.

Forms and updates

You may be asked to fill out detailed forms about your history. Answer honestly and completely, and ask the firm for help with anything you do not remember. Large drug cases often take years, so ask how often the firm sends updates and how to reach your contact person.

Staying in touch over time

Large drug cases can stretch on for years, and life changes along the way. Tell the firm right away if you move, change your phone number or email, or switch doctors.

Also let the firm know if you get a new diagnosis, start a new treatment or are admitted to the hospital. If you receive letters or calls about your case from anyone else, forward them to your firm before you respond.

Keep a simple log of each call or email with the firm, including the date and what was discussed. This helps you remember next steps and makes it easy to follow up if you have not heard back.

Your health stays first

A Dupixent lymphoma case should never get in the way of your care. Keep all your medical appointments and follow your treatment team’s advice. Let the firm know if your health changes, because that can matter to your case.

How to Check a Law Firm Before You Sign

It is wise to learn a little about any firm before you sign up for a Dupixent lymphoma case. These simple checks can give you peace of mind.

• Look up the lawyer’s license. Every state bar has a public lookup tool that shows whether a lawyer is licensed and in good standing.
• Ask who will do the work. Some firms work with other firms on large drug cases. Ask who will be your main contact and who will handle court filings.
• Read the fee agreement slowly. Check the percentage, how case costs are handled and what happens if you decide to change lawyers.
• Do not pay up front for a review. A free case review should be free. Be cautious of anyone who asks for money to “hold your spot” in a Dupixent lymphoma lawsuit.
• Watch for pressure. You should never feel rushed to sign the same day. A trustworthy firm will give you time to think.
• Ask about privacy. Find out how the firm stores your medical records and who can see them.

If something feels off, it is fine to pause and ask another firm for a review. Choosing a firm to handle your Dupixent lymphoma claim is your decision.

Common Myths About a Dupixent Lymphoma Case Review

Many people put off asking because of things they have heard. Here are some common myths about a Dupixent lymphoma review, and what is usually true instead.

Myth: Asking for a review means I am suing someone

A review is only a conversation. Nothing is filed unless you sign an agreement with a firm and decide to move forward.

Myth: I need all my medical records first

Most reviews start with basic facts. A firm that takes your Dupixent lymphoma case can often help request the records later, with your written permission.

Myth: I have to stop Dupixent to ask

No. Your treatment is between you and your doctor. Dupixent has not been recalled, and you should not stop or change any medicine without medical advice.

Myth: This is a class action, so I will be included automatically

MDL 3180 is not a class action. Each person who wants to take part generally needs their own case, which is one reason to ask about a Dupixent lymphoma claim instead of waiting.

Myth: Someone can tell me what my case is worth

No Dupixent lymphoma case has been tried or settled, and there are no settlement amounts. Be cautious of anyone who quotes a dollar figure.

Myth: It is too late because I was diagnosed years ago

Maybe, maybe not. Deadlines vary by state and claim type, and some depend on when you learned about a possible link to the drug. A firm can look at your dates and explain where you stand.

Special Situations in a Dupixent Lymphoma Review

Not every story fits a simple form. Here is how some common situations are usually handled. A participating law firm can tell you how its own criteria apply.

You used Dupixent for asthma or another condition

Dupixent is approved for several conditions, not just eczema. The lawsuits focus on the drug and the CTCL diagnosis, so tell the firm what you were treated for and when.

The patient is a child or teen

Dupixent is also prescribed to children. A parent or guardian usually asks for a review on a minor’s behalf. Deadlines for minors can work differently, and they vary by state.

Your diagnosis was a different T-cell lymphoma

The MDL currently covers CTCL and its subtypes. If you have another T-cell lymphoma, ask anyway. The JPML said it could decide later whether those cases belong in the MDL.

You already talked to a lawyer

If you signed with a firm already, contact that firm first with questions about your Dupixent lymphoma claim. If you only had a phone call and signed nothing, you are generally free to ask for another review.

You moved to a new state

Tell the firm every state where you lived while using Dupixent and when you were diagnosed. The state that matters for filing deadlines is not always the one you live in now.

Whatever your situation, the first step is the same. Share the basics, ask your questions and take your time deciding what is right for you after a Dupixent lymphoma diagnosis.

Dupixent lymphoma: frequently asked questions

How Direct2Attorney can help

If you or a loved one used Dupixent and later received a lymphoma diagnosis, you can start a free Dupixent lymphoma case review on our Dupixent lawsuit page. We will connect you with a participating law firm that may review your situation. To get ready, see the records a Dupixent CTCL claim needs.

Direct2Attorney is a legal marketing and referral service, not a law firm. This article is general information, not legal advice. Submitting information does not create an attorney-client relationship.